Search

Your search keyword '"Fluocinolone acetonide -- Usage"' showing total 7 results
Start Over Descriptor "Fluocinolone acetonide -- Usage"
7 results on '"Fluocinolone acetonide -- Usage"'

1. Phase 4 PALADIN Study Confirms Positive Predictive Value of Corticosteroid Course Prior to ILUVIENA Use for IOP Outcomes

Subjects
Corticosteroids -- Usage, Fluocinolone acetonide -- Usage, Ophthalmology -- Usage, Fluocinolone -- Usage, Business, international, Iluvien (Medication) -- Usage
Abstract

(GlobeNewswire) - Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better [...]

Published
2022

2. Phase 4 PALADIN Study Confirms Positive Predictive Value of Corticosteroid Course Prior to ILUVIEN(R) Use for IOP Outcomes

Subjects
Corticosteroids -- Usage, Fluocinolone acetonide -- Usage, Ophthalmology -- Usage, Fluocinolone -- Usage, Banking, finance and accounting industries, Business, Iluvien (Medication) -- Usage
Abstract

ATLANTA, May 12, May 12, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NasdaqGM:ALIM), EQNX::TICKER_END Alimera Sciences, Inc. (Nasdaq: ALIM) ('Alimera'), a global pharmaceutical company whose mission is to be invaluable [...]

Published
2022

3. Clinical: Journals Watch - TIA, CVD risk and influenza

Subjects
Swine influenza -- Diagnosis -- Causes of -- Care and treatment -- Research, Cerebral ischemia -- Diagnosis -- Causes of -- Care and treatment -- Research, Fluocinolone acetonide -- Usage, Cardiovascular diseases -- Diagnosis -- Risk factors -- Drug therapy -- Research, News, opinion and commentary
Abstract

Have you been too busy to read the journals? Dr Louise Newson brings you the latest research. - Patients with TIAs are still not going to emergency departments. Emerg Med [...]

Published
2010

4. Early neuroschistosomiasis complicating Katayama syndrome

Author

Clerinx, Jan, van Gompel, Alfons, Lynen, Lut, and Ceulemans, Berten

Subjects
Schistosomiasis -- Diagnosis, Schistosomiasis -- Risk factors, Schistosomiasis -- Prevention, Fluocinolone acetonide -- Usage
Abstract

To the Editor: Neurologic complications of schistosomiasis may occur early as well as late in the course of infection; they result when a pair of worms becomes lodged in the [...]

Published
2006

5. Adjunct dexamethasone therapy for hematogenous suppurative arthritis

Subjects
Fluocinolone acetonide -- Usage, Dexamethasone -- Usage, Health
Abstract

Synopsis: Short-course (4 days) adjunct dexamethasone therapy for hematogenous suppurative arthritis in children shortened the duration of symptoms during the acute phase and reduced residual dysfunction at the end of [...]

Published
2004

6. Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial

Author

Dalziel, Stuart R., Liang, Allen, Parag, Varsha, Rodgers, Anthony, and Harding, Jane E.

Subjects
Fluocinolone acetonide -- Usage, Fluocinolone acetonide -- Research, Respiratory distress syndrome -- Care and treatment, Respiratory distress syndrome -- Research, Prenatal drug exposure -- Research, Betamethasone -- Usage, Betamethasone -- Risk factors, Betamethasone -- Research
Abstract

Objective. To determine whether prenatal exposure to betamethasone for the prevention of neonatal respiratory distress syndrome (RDS) alters blood pressure in childhood. Design. Prospective follow-up study of a randomized, double-blind, placebo-controlled trial. Setting. National Women's Hospital (Auckland, New Zealand). Participants. Two hundred twenty-three 6-year-old children of mothers who presented with unplanned premature labor and took part in a randomized, controlled trial of prenatal betamethasone therapy for the prevention of neonatal RDS. Intervention. Mothers received 2 doses of betamethasone (12 mg) or placebo, administered through intramuscular injection, 24 hours apart. Main Outcome Measures. Systolic and diastolic blood pressure at 6 years of age. Results. Children exposed prenatally to betamethasone (n = 121) did not differ in systolic or diastolic blood pressure from children exposed to placebo (n = 102) (mean difference: systolic: -1.6 mm Hg; 95% confidence interval: -4.1 to 0.8 mm Hg; diastolic: -0.3 mm Hg; 95% confidence interval: -2.5 to 1.8 mm Hg). Conclusion. Prenatal exposure to betamethasone for prevention of neonatal RDS does not alter blood pressure at 6 years of age. Pediatrics 2004;114:e373-e377. URL: http://www.pediatrics.org/cgi/content/full/114/3/e373; prenatal glucocorticoids, respiratory distress syndrome, blood pressure, long-term follow-up.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results